NCT06575218 · RECRUITING

The Effectiveness of Virtual Reality Training Program

This trial is testing whether a virtual reality training program improves cognition in people already diagnosed with Alzheimer's disease. Participants are compared against a group doing conventional exercise and cognitive exercise, and a control group. This is a Phase NA study, meaning it is a straightforward clinical trial focused on measuring effectiveness rather than early-stage safety testing. Details on sample size and duration are limited in the source.

You may qualify if

  • ≥ 55 years and older Diagnosed with AD according to DSM-IV diagnostic criteria by a neurologist, MOCA ≥ 16 Clinical Dementia Rating Scale \< 2

You're excluded if

  • Various mobility restrictions, musculoskeletal disorders, (wheelchair use, etc.) Clinically significant aphasia (must be able to understand the therapist's commands) Significant visual or sensory impairment

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-08-30

View full record on ClinicalTrials.gov

All APOE4 clinical trials